Health and Fitness Health and Fitness
Tue, September 28, 2010
[ Tue, Sep 28th 2010 ] - Market Wire
ARIAD to Present at the Jefferies Global SpecPharma and European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Unigene Expands Board of Directors; Elects Joel A. Tune as Director
[ Tue, Sep 28th 2010 ] - Market Wire
Oncolytics Biotech Inc. Announces Issuance of Key U.S. Patent
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien unter den Referenten auf der Jefferies European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Presentazione di Covidien alla Jefferies European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien effectuera une pr©sentation dans le cad .. europ©enne de Jefferies sur les soins de sant©
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien se presentar en la Conferencia Europea sobre el cuidado de la salud Jefferies
[ Tue, Sep 28th 2010 ] - Market Wire
Covidien to Present at Jefferies European Healthcare Conference
[ Tue, Sep 28th 2010 ] - Market Wire
AngioDynamics to Report Fiscal 2011 First Quarter .. sults and Hold Conference Call on October 7, 2010
[ Tue, Sep 28th 2010 ] - Market Wire
AVEO Pharmaceuticals, Inc. to Present at Upcoming .. cology Medical Meetings and Investment Conference
[ Tue, Sep 28th 2010 ] - Market Wire
SuperGen to Present at BIO Investor Forum on October 5th
[ Tue, Sep 28th 2010 ] - Market Wire
Pieris Signs Broad Collaboration With Sanofi-Aven .. Sanofi Pasteur to Develop Anticalin Therapeutics
Mon, September 27, 2010
[ Mon, Sep 27th 2010 ] - Market Wire
Kindred Healthcare Acquires Three Nursing and Reh .. enters in Dallas-Fort Worth, Texas Cluster Market
[ Mon, Sep 27th 2010 ] - Market Wire
Alcon Announces Third Quarter 2010 Financial Release and Conference Call Dates
[ Mon, Sep 27th 2010 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of NightHawk Radiology Holdings, Inc.
[ Mon, Sep 27th 2010 ] - Market Wire
Bioniche Experiences Increased Trading Activity
[ Mon, Sep 27th 2010 ] - Market Wire
Powers Taylor Law Firm Investigates NightHawk Rad .. rning the Acquisition by Virtual Radiologic Corp.
[ Mon, Sep 27th 2010 ] - Market Wire
Tenet Announces Lake Pointe Medical Center Appoints New Hospital CEO
[ Mon, Sep 27th 2010 ] - Market Wire
Valeant and Biovail Announce Results of Special Meetings of Shareholders
[ Mon, Sep 27th 2010 ] - Market Wire
Transcend Introduces its Next Generation Platform - ENCORE
[ Mon, Sep 27th 2010 ] - Market Wire
Kendall Law Group Investigates NightHawk Radiology Holdings Acquisition for Shareholders
[ Mon, Sep 27th 2010 ] - Market Wire
ROBERT BURGESS APPOINTED TO IMRIS BOARD OF DIRECTORS
[ Mon, Sep 27th 2010 ] - Market Wire
Aetna Signs Contract Extension with Crozer-Keystone Health System
[ Mon, Sep 27th 2010 ] - Market Wire
Sanofi Pasteur to Acquire VaxDesign, a U.S. Biotechnology Company
[ Mon, Sep 27th 2010 ] - Market Wire
Clark Marcus Appointed Sole Chief Executive Officer of Comprehensive Care Corporation
[ Mon, Sep 27th 2010 ] - Market Wire
ZIOPHARM Granted Japanese Patent for Darinaparsin
[ Mon, Sep 27th 2010 ] - Market Wire
Progenics Extends Agreement with Pfizer for RELISTOR Commercialization
[ Mon, Sep 27th 2010 ] - Market Wire
Trimeris and Roche Reach Agreement on Trimeris Repayment of Deferred Marketing Expense
[ Mon, Sep 27th 2010 ] - Market Wire
Hi-Tech Pharmacal Will Market Generic Buprenorphine HCl Sublingual Tablets
[ Mon, Sep 27th 2010 ] - Market Wire
Emergent BioSolutions to Participate in October 2010 Investor Conferences

Emergent BioSolutions to Participate in October 2010 Investor Conferences


Published on 2010-09-27 04:35:21 - Market Wire
  Print publication without navigation


ROCKVILLE, Md.--([ BUSINESS WIRE ])--Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company will be participating in the following investor conferences in October 2010.

  • The 9th Annual BIO Investor Forum
    San Francisco, CA.
    October 5, 2010
    Corporate Overview Presentation
    9:00 AM Pacific
    [The presentation, which will include a discussion of the Companya™s business activities, financial outlook and current news, will be webcast live.]
  • The 17th Annual BioCentury/Thomson Reuters Newsmakers in the Biotech Industry Conference
    New York, NY.
    October 22, 2010
    Corporate Overview Presentation
    2:00 PM Eastern
    [The presentation, which will include a discussion of the Companya™s business activities, financial outlook and current news, will be webcast live.]

Both webcasts will be accessible from the Emergent website [ www.emergentbiosolutions.com ] under aInvestorsa.

About Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodya™s immune system to prevent or treat disease. Emergenta™s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergenta™s product pipeline targets infectious diseases and includes programs focused on anthrax, tuberculosis, typhoid, flu and chlamydia. Additional information may be found at [ www.emergentbiosolutions.com ].

Contributing Sources